Is Asthma a Risk Factor for Coronavirus Disease-2019 Worse Outcomes?

The Answer Is No, But...

Priscila A. Franco; Sergio Jezler; Alvaro A. Cruz


Curr Opin Allergy Clin Immunol. 2021;21(3):223-228. 

In This Article

Is there a Place for Telemedicine for Asthma Management During the Pandemics?

In this challenging scenario of high prevalence of asthma and an epidemic of a novel and potentially lethal and highly contagious viral respiratory infection, telemedicine can be an option to maintain medical monitoring during the pandemic, helping reducing patients' anxiety and stress, maintaining the asthma control and minimizing the risk of transmission. However, there are limitation to assessment without visual clues and when equipment, such as a pulse oximeter or peak flow are not available to objectively evaluate the patients. For mild cases, assessment via telephone or video may be enough, but evaluation by video must be used preferentially to approach patients with acute symptoms and greater risk.[33] We often need to differentiate whether the patient has an exacerbation of asthma or COVID-19. It is not always simple even in a regular consultation. Both can present with cough and breathlessness, but specific features may indicate COVID-19, such as fever, onset of dyspnea between 4 and 8 days into the illness, flu-like symptoms and absence of wheezing.[34]